FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

7602611000001102: Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20435501000001114 Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
20435601000001113 Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39169501000001116 Trisenox 10mg/10ml concentrate for solution for infusion ampoules (Cephalon UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
67062301000001114 Trisenox 10mg/10ml concentrate for solution for infusion ampoules (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Is a Arsenic 10mg/10ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has active ingredient Arsenic trioxide false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has active ingredient Arsenic trioxide false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Is a Trisenox true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has specific active ingredient Arsenic trioxide true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Has active ingredient Arsenic true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Is pack of False Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has AMP True Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start